Incretin-like effects of small molecule trace amine-associated receptor 1 agonists

OBJECTIVE: Type 2 diabetes and obesity are emerging pandemics in the 21st century creating worldwide urgency for the development of novel and safe therapies. We investigated trace amine-associated receptor 1 (TAAR1) as a novel target contributing to the control of glucose homeostasis and body weight...

Descripción completa

Detalles Bibliográficos
Autores principales: Raab, Susanne, Wang, Haiyan, Uhles, Sabine, Cole, Nadine, Alvarez-Sanchez, Ruben, Künnecke, Basil, Ullmer, Christoph, Matile, Hugues, Bedoucha, Marc, Norcross, Roger D., Ottaway-Parker, Nickki, Perez-Tilve, Diego, Conde Knape, Karin, Tschöp, Matthias H., Hoener, Marius C., Sewing, Sabine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4703809/
https://www.ncbi.nlm.nih.gov/pubmed/26844206
http://dx.doi.org/10.1016/j.molmet.2015.09.015

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4703809/
https://www.ncbi.nlm.nih.gov/pubmed/26844206
http://dx.doi.org/10.1016/j.molmet.2015.09.015

Ejemplares similares